Microbiology / Infectious Disease
Join Mayo Clinic Laboratories for our webinar exploring the expanding role of precision diagnostics in the evaluation of serious and potentially life-threatening infections. Focusing on metagenomic sequencing available from Mayo Clinic Laboratories, including the Karius Spectrum plasma test, which is offered by Mayo Clinic Laboratories in collaboration with Karius, participants will gain an overview of microbial cell-free DNA (mcfDNA) metagenomic sequencing, including clinical decision-making around test ordering, appropriate clinical indications, and how to interpret and apply results to support timely diagnosis and patient management.
Explore why traditional microscopy is challenging, how AI-assisted review works, what workflow changes are required, and how validation data can support implementation decisions.
Tick-borne diseases are increasing across the United States as tick populations and their geographic range continue to expand. This presentation reviews current trends in tick-borne diseases, highlights major tick vectors and associated pathogens, discusses prevention strategies, and explores the laboratory's role in supporting accurate diagnosis and patient care.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, speaks with William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, about Ebola, hantavirus and takeaways from a recent healthcare conference. Later, she welcomes Elli Theel, Ph.D., a microbiologist in Mayo Clinic’s Department of Laboratory Medicine and Pathology, to explore vector-borne diseases.
PACE/FL - Four case studies to explore key diagnostic considerations when Lyme testing is negative, highlight the role of geographic exposure history, and demonstrate the utility of multiplex testing panels
Discover how efficient, evidence-based serologic testing algorithms can accelerate Coccidioides infection diagnosis, simplify laboratory workflow, and provide practical benefits for laboratorians and healthcare professionals.
The Mayo Clinic Parasitology Workshop offers an immersive learning experience focused on practical skills for parasite identification. This two-day program combines expert-led presentations with hands-on laboratory sessions to help participants apply diagnostic techniques with confidence. Reserve your spot today.
Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.
Registration is now open for the 2026 Mayo Clinic Parasitology Workshop. This interactive two-day program is designed to enhance your diagnostic skills through expert-led lectures and hands-on laboratory sessions.
Explore the intersection of medical science and personal well-being. In this informative and engaging presentation, Bobbi Pritt, M.D., draws on her expertise in clinical microbiology and parasitology to illuminate how the study of parasites offers valuable lessons for health, resilience, and lifelong growth.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and the first reported death from alpha-gal syndrome. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer and medical director of BioPharma Diagnostics, to explore how biopharma diagnostics advance research and development.